FOXO4-DRI (Injectable) in Louisiana

Pepti serves all of Louisiana. A physician licensed in Louisiana reviews every order within 4 hours, the prescription is compounded by a state-licensed, FDA-registered pharmacy, and it ships free and tracked to any Louisiana street address. The price is the same as every other state.

Yes. The whole process is online in Louisiana: a free assessment, physician review, messaging, dose changes, and refills through your Pepti account or the Hello Pepti app. No clinic visit is required.

Pepti ships FOXO4-DRI to Louisiana directly from the pharmacy: free, tracked, unbranded, in insulated packaging with ice packs for refrigerated medication. The pharmacy ships the next business day and it arrives overnight. PO Boxes are not accepted.

Every treatment on Pepti's catalog ships to Louisiana. Eligibility is confirmed during the assessment from your Louisiana shipping address, and if anything ever cannot ship to your address it is refunded.

The same as everywhere Pepti serves: one all-in monthly price per treatment that includes the medication, the physician, and shipping, with no Louisiana-specific markup and no membership or consult fee. Every price is on the product page.

Yes. Pepti's physicians hold licenses in Louisiana, and only a physician licensed where you live reviews and prescribes your order. Their names and credentials are on the providers page.

Yes. Pepti's partner pharmacies are state-licensed, FDA-registered 503A compounding pharmacies licensed to dispense into Louisiana, and every batch is independently tested before it ships.

FOXO4-DRI is a research peptide studied for clearing senescent cells, the worn-out cells that stop dividing but linger and drive inflammation as we age. Human evidence is limited, so it is prescribed only where a physician judges it appropriate. Compounded; not FDA-approved. FOXO4-DRI is prescription-only at Pepti: a licensed physician reviews your assessment and, if appropriate, prescribes it to be compounded by a state-licensed, FDA-registered pharmacy.

FOXO4-DRI is commonly prescribed for: Adults pursuing a longevity protocol under physician supervision; People who feel recovery, energy and skin have slowed with age and want to work on the cellular side of it; Patients who understand the evidence is from animal studies and are comfortable with that; Someone who wants a longevity peptide that is not a hormone. Whether it is appropriate for you is decided by the reviewing physician from your history, medications, and labs where required.

Yes. FOXO4-DRI is prescription-only. The free online assessment takes about five minutes, a physician licensed in Louisiana reviews it within 4 hours, and if approved the prescription goes to the pharmacy. If not approved, the medication charge is refunded.

No. FOXO4-DRI can be prescribed from the assessment alone. If your physician wants labs for your care, they'll ask through your account; upload a recent lab report from any lab at no charge, or order Pepti's at-home panel.

FOXO4-DRI is a subcutaneous injection into the abdomen or thigh with a small insulin syringe. Your kit ships with sterile syringes and alcohol prep pads, and the exact dose and schedule are printed on the pharmacy label. Dosing videos are in your account.

One vial is your monthly supply at the dose your physician prescribes. A fresh vial ships about every 28 days, and the date moves if your physician changes your dose. Store it as the pharmacy label directs, refrigerated.

Once per fill, $229 each time, when the next vial ships. It renews until you cancel, which you can do anytime from your account with no cancellation fee.

The compounded FOXO4-DRI with sterile syringes and alcohol prep pads, free tracked shipping in an unbranded box with insulated packaging, the physician review, ongoing physician care and dose adjustments, and unlimited messaging.

Reported side effects of FOXO4-DRI are usually mild: mild redness or swelling at injection site; temporary fatigue or headache; mild nausea (uncommon). The physician screens your history, medications, and allergies before prescribing, the medication-specific consent lists the known risks, and you can message your physician about anything you notice. Seek emergency care for severe symptoms.

Response varies by person, goal, and dose, and FOXO4-DRI is prescribed for ongoing use rather than a short trial. Your physician sets expectations at approval, tracks how you respond through your account, and adjusts the dose without an appointment.

Yes. Request it from your account or the app; your physician approves or declines. If approved you pay for the additional medication at the pharmacy's cost and the new dose applies to your next shipment.

Yes. Add FOXO4-DRI to a plan with another treatment and both go through one assessment and one physician review, shipping together on one schedule. Each keeps its own catalog price. The physician reviews the combination and can adjust it.

No. Compounded FOXO4-DRI is not FDA-approved. It is prepared to your physician's prescription by a state-licensed, FDA-registered 503A pharmacy and every batch is independently tested before release.

Yes, when prescribed by a licensed physician and dispensed by a licensed pharmacy, which is how Pepti provides it in Louisiana. Research-use-only FOXO4-DRI sold without a prescription is labeled not for human use and is a different product.

Old, worn-out cells survive by holding a protein called p53 in check. At Pepti it is prescribed to support studied for clearing worn-out cells, a longevity research peptide, evidence is from animal studies, daily injection, monday to friday. Individual response varies, and your physician sets expectations at approval.

Old, worn-out cells survive by holding a protein called p53 in check. FOXO4-DRI breaks that hold inside those cells only, so they self-destruct while healthy cells are left alone. Clearing them is studied for reducing the low-grade inflammation of aging. Compounded FOXO4-DRI is not FDA-approved; it is prescribed off-label by a licensed physician after reviewing your assessment.

FOXO4-DRI is prescribed for studied for clearing worn-out cells, a longevity research peptide, evidence is from animal studies, daily injection, monday to friday. It is commonly requested by adults pursuing a longevity protocol under physician supervision; people who feel recovery, energy and skin have slowed with age and want to work on the cellular side of it; patients who understand the evidence is from animal studies and are comfortable with that; Someone who wants a longevity peptide that is not a hormone. Whether it is appropriate for you is the reviewing physician's decision.

FOXO4-DRI is studied for studied for clearing worn-out cells, a longevity research peptide, evidence is from animal studies, daily injection, monday to friday. Those are the goals it is prescribed to support at Pepti; results vary by person, dose, and consistency, and no outcome is guaranteed. Your physician tracks how you respond through your account.

In aged mice, a 2017 study (Baar and colleagues, Cell) reported cleared senescent cells, thicker fur, more activity and improved kidney function. There are no published controlled human trials. References are listed on this page.

FOXO4-DRI is generally not prescribed with: active cancer or history of cancer (unless approved by oncologist); pregnancy or breastfeeding; severe kidney or liver disease; known allergy to the peptide or excipients. The physician screens for these in your intake, and anything that rules FOXO4-DRI out means it is not prescribed and is refunded.

At Pepti. Complete the free assessment, a physician licensed in Louisiana reviews it within 4 hours, and if appropriate FOXO4-DRI is compounded by a state-licensed, FDA-registered pharmacy and shipped free to your door for $229 per month, all-in. Not prescribed means refunded.

Injectable vial: 5 mL at 2 mg/mL, containing 10 mg FOXO4-DRI. One vial is your monthly supply at the prescribed dose, and a fresh one ships about every 28 days.

Not currently. FOXO4-DRI ships as a multi-dose vial with sterile syringes and prep pads. The pepti Pen is available for 24 other treatments.

$229 per month covers the compounded FOXO4-DRI, the physician review, ongoing physician care including dose adjustments and refill review, unlimited messaging, and free tracked shipping. There is no membership, consult, visit, or refill fee; the only separate charges are optional at-home lab panels and a physician-approved dose increase billed at pharmacy cost.

Yes. FOXO4-DRI is on Pepti's live catalog, which lists only treatments a partner pharmacy can compound and ship today. If a physician prescribes it, it ships; if it ever cannot be dispensed, the charge is refunded.

FOXO4-DRI ships to 49 states and Washington, D.C, free and tracked, in insulated unbranded packaging. Eligibility is confirmed during the assessment from your shipping address.